Sage Therapeutics, Inc. (SAGE) Financials

SAGE Assets vs Liabilities
DateAssetsLiabilities
June 30, 2025 422.9 million 54.2 million
March 31, 2025 469.7 million 59.8 million
Dec. 31, 2024 547.2 million 82.1 million
Sept. 30, 2024 622.4 million 70.6 million

SAGE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2025 -58.7 million 8.7 million
March 31, 2025 -81.7 million 6.9 million
Dec. 31, 2024 -66.6 million 9.4 million
Sept. 30, 2024 -82.4 million 14.2 million

SAGE Net Income

No data available :(

SAGE Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2025 365.6 million 19.1 million 9.5 million
March 31, 2025 423.9 million 10.0 million 11.9 million
Dec. 31, 2024 504.4 million 10.5 million 11.8 million
Sept. 30, 2024 569.2 million 10.2 million 10.3 million

SAGE Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2025 62.6 million
March 31, 2025 61.9 million
Dec. 31, 2024 60.8 million
Sept. 30, 2024 61.1 million

SAGE Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2025 - 23.9 million 62.0 million -
March 31, 2025 - 22.8 million 57.6 million -
Dec. 31, 2024 - 37.0 million 54.6 million -
Sept. 30, 2024 - 54.6 million 53.2 million -

SAGE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2025 31.7 million -55000
March 31, 2025 14.1 million 655000
Dec. 31, 2024 12.8 million 1.5 million
Sept. 30, 2024 11.9 million 5.3 million

SAGE Revenue by Segment
Graph available only for paid members. Upgrade to see it.

SAGE

Price: $8.68

52 week price:
4.62
9.36

Earnings Per Share: -4.89 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 427700

Ebitda: -74.2 million

Market Capitalization: 544.9 million

Links: